Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3619918rdf:typepubmed:Citationlld:pubmed
pubmed-article:3619918lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3619918lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:3619918lifeskim:mentionsumls-concept:C0001942lld:lifeskim
pubmed-article:3619918lifeskim:mentionsumls-concept:C0010654lld:lifeskim
pubmed-article:3619918lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:3619918lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:3619918lifeskim:mentionsumls-concept:C1706204lld:lifeskim
pubmed-article:3619918lifeskim:mentionsumls-concept:C1555721lld:lifeskim
pubmed-article:3619918lifeskim:mentionsumls-concept:C1711351lld:lifeskim
pubmed-article:3619918lifeskim:mentionsumls-concept:C0027289lld:lifeskim
pubmed-article:3619918pubmed:issue3lld:pubmed
pubmed-article:3619918pubmed:dateCreated1987-9-21lld:pubmed
pubmed-article:3619918pubmed:abstractTextThe beta 3 beta 3 (formerly called beta Indianapolis) and beta 1 beta 1 isoenzymes of human alcohol dehydrogenase differ substantially in their catalytic properties. Specifically, the KM value for NAD+ of beta 3 beta 3 is 70 times greater than that of beta 1 beta 1, and the Ki value for NADH is 35 times greater than that of beta 1 beta 1. To identify the structural basis of these catalytic differences, we sequenced regions of the beta 3 subunit and the beta 3 gene. beta 3 differs from beta 1 by the substitution of Cys for Arg-369. Based on x-ray crystallography of horse ADH, Arg-369 should interact with the nicotinamide phosphate moiety of NAD(H). The Cys for Arg-369 substitution would decrease the enzyme's affinity for coenzyme and, thus, account for the observed kinetic differences between beta 3 beta 3 and beta 1 beta 1.lld:pubmed
pubmed-article:3619918pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3619918pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3619918pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3619918pubmed:languageenglld:pubmed
pubmed-article:3619918pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3619918pubmed:citationSubsetIMlld:pubmed
pubmed-article:3619918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3619918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3619918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3619918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3619918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3619918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3619918pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3619918pubmed:statusMEDLINElld:pubmed
pubmed-article:3619918pubmed:monthAuglld:pubmed
pubmed-article:3619918pubmed:issn0006-291Xlld:pubmed
pubmed-article:3619918pubmed:authorpubmed-author:BosronW FWFlld:pubmed
pubmed-article:3619918pubmed:authorpubmed-author:LiT KTKlld:pubmed
pubmed-article:3619918pubmed:authorpubmed-author:EdenbergH JHJlld:pubmed
pubmed-article:3619918pubmed:authorpubmed-author:DwuletF EFElld:pubmed
pubmed-article:3619918pubmed:authorpubmed-author:CarrL GLGlld:pubmed
pubmed-article:3619918pubmed:authorpubmed-author:BurnellJ CJClld:pubmed
pubmed-article:3619918pubmed:issnTypePrintlld:pubmed
pubmed-article:3619918pubmed:day14lld:pubmed
pubmed-article:3619918pubmed:volume146lld:pubmed
pubmed-article:3619918pubmed:ownerNLMlld:pubmed
pubmed-article:3619918pubmed:authorsCompleteYlld:pubmed
pubmed-article:3619918pubmed:pagination1127-33lld:pubmed
pubmed-article:3619918pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:meshHeadingpubmed-meshheading:3619918-...lld:pubmed
pubmed-article:3619918pubmed:year1987lld:pubmed
pubmed-article:3619918pubmed:articleTitleThe human beta 3 alcohol dehydrogenase subunit differs from beta 1 by a Cys for Arg-369 substitution which decreases NAD(H) binding.lld:pubmed
pubmed-article:3619918pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3619918pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
entrez-gene:125entrezgene:pubmedpubmed-article:3619918lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3619918lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3619918lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3619918lld:pubmed